Why is TTK Healthcare falling/rising?

As of 23-Sep, TTK Healthcare Ltd. is experiencing a decline in its stock price, currently at 1,186.50, which reflects a decrease of 8.5 or 0.71%. The stock has underperformed its sector today by 0.36%, and despite a recent increase in investor participation, as indicated by a 25.79% rise in delivery volume, it has not translated into positive price movement. Over the past week, the stock has shown a modest gain of 1.32%, but it has significantly underperformed over the longer term, with a 29.86% drop in the last year. The company's financial performance has also been concerning, with a recent quarterly profit after tax falling by 20.1%, and its operating profit to net sales at a low of 1.18%. Additionally, the stock is trading at a premium compared to its peers, which may deter potential investors.
In the broader market context, TTK Healthcare's short-term performance contrasts with the Sensex, which has declined by 0.34% over the same week. While the stock has shown some resilience in the short term, its long-term performance is troubling, with a 16.25% decline year-to-date compared to a 5.07% gain in the Sensex. The low stake held by domestic mutual funds, at only 0.17%, suggests a lack of confidence in the stock's valuation, further contributing to its downward pressure. Overall, the combination of disappointing financial results, underperformance relative to benchmarks, and cautious sentiment from institutional investors indicates a challenging environment for TTK Healthcare's stock.